Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2792
Source ID: NCT00622089
Associated Drug: Dio-902
Title: Open Label Safety & Pharmacodynamic Study 24Wk w/DIO-902 Combo w/Metformin & Atorvastatin in T2DM Patients
Acronym:
Status: TERMINATED
Study Results: NO
Results:
Conditions: Type 2 Diabetes
Interventions: DRUG: DIO-902|DRUG: DIO-902|DRUG: DIO-902
Outcome Measures: Primary: The following parameters will be evaluated at Week 12 and Week 24: • Proportion of subjects who reach the lipid goal as defined in the protocol from baseline • Proportion of subjects who meet the HbA1c goal as defined in the protocol from baseline, 24 weeks |
Sponsor/Collaborators: Sponsor: DiObex
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2|PHASE3
Enrollment: 150
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2008-01
Completion Date: 2008-12
Results First Posted:
Last Update Posted: 2008-05-28
Locations: Dr. Terence Hart, Muscle Shoals, Alabama, 35662, United States|Genova Research, Tucson, Arizona, 85741, United States|Research Solutions, Jonesboro, Arkansas, 72401, United States|Arkansas Primary Care Clinic, Little Rock, Arkansas, 72211, United States|Advanced Medical Research, Lakewood, California, 90712, United States|Mills-Peninsula Helath Services, San Mateo, California, 94401, United States|Diabetes Research Goup University of Hawaii at Manoa, Honolulu, Hawaii, 96813, United States|Creighton Diabetes Center, Omaha, Nebraska, 68131, United States|AHS Oklahoma Physician Group, Tulsa, Oklahoma, 74104, United States|Covance Clinical Research Unit - Dr. Andrew Ahmann, Portland, Oregon, 927239, United States|Covance CRU, Austin, Texas, 78752, United States|Diabetes Glandular Disease Research Associates, San Antonio, Texas, 78229, United States|Flinders Medical Centre, Adelaide, South Australia, Australia|Lyell McEwin Hospital, North Western Adelaide, South Australia, Australia|ECRU, Box Hill, Melbourne, Victoria, Australia|School of Medicine and Pharmacology, Fremantle, Western Australia, 6160, Australia|Keough Institute, Nedands, Western Australia, 6009, Australia|Endocrinology Research Unit, Herston Road, QLD 4029, Australia|Endocrinology Department, St Leonards, NSW 2065, Australia|Royal Melbourn Hospital, Victoria, Australia|Middlemore Hospital, Otahuhu, Auckland, New Zealand|Lipid and Diabetes Research, Christchurch, New Zealand|Waikaito Hospital, Hamilton, New Zealand|Diabetes Centre, Wellington, New Zealand
URL: https://clinicaltrials.gov/show/NCT00622089

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress
D438 Levoketoconazole small molecule DB05667 Details